Loading...
XSHE
002462
Market cap471mUSD
Jul 09, Last price  
10.96CNY
1D
-1.26%
1Q
-24.78%
IPO
-29.20%
Name

Cachet Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:002462 chart
P/E
28.70
P/S
0.16
EPS
0.38
Div Yield, %
1.55%
Shrs. gr., 5y
0.04%
Rev. gr., 5y
-5.29%
Revenues
19.53b
-18.71%
662,903,000965,221,7981,133,559,8451,341,671,1341,801,380,2392,554,073,3033,544,275,1665,572,152,3398,199,831,90810,971,576,55614,238,899,71617,959,885,46622,186,572,87323,256,135,89125,625,618,76926,219,790,24426,219,790,24429,996,240,36124,018,607,69419,525,150,161
Net income
111m
-30.68%
182,625,34341,356,80742,418,31248,542,36963,682,54965,209,646130,168,778228,060,092172,976,472223,099,562263,641,644327,633,241375,957,181317,585,429353,876,779468,312,507296,935,794250,060,047160,668,367111,378,719
CFO
1.39b
+671.92%
054,833,05150,116,113-49,607,20848,574,6100000116,304,01300293,114,5561,114,869,517913,127,42301,595,439,529180,355,1871,392,196,485
Dividend
Jun 30, 20250.17 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in Beijing, China, in 1998, Cachet Pharmaceutical Co., Ltd. is a prominent Chinese enterprise engaged in the comprehensive wholesale and retail trade of pharmaceutical goods. The company's operations are multifaceted, encompassing the provision of medicines to hospitals, the large-scale distribution of biological products, medical devices, and traditional Chinese remedies. Additionally, it handles pharmaceutical logistics and actively manufactures its own line of medications. In Beijing, Cachet Pharmaceutical maintains a significant retail footprint with 150 chain stores, where customers can find a wide array of products, including pharmaceuticals, health supplements, medical instruments, cosmetics, daily essentials, and traditional Chinese medicines.
IPO date
Aug 18, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT